Hunniwell Lake Ventures
SEC exempt reporting adviser (venture capital exemption).
- Website
- http://www.hunniwell.com
- HQ
- CA
Hunniwell Lake Ventures invests in extensions of proven technologies within overlooked segments of the medical device space, operating from the heart of Silicon Valley. The team includes founders Richard Fang and Daniel Teo, plus David Schechter, John Ashley, David Yeow, and Matthew Otten. Portfolio companies include Picard Medical, whose subsidiary SynCardia Systems is a pioneer in Total Artificial Heart technology, and CoapTech, which is developing the Pediatric PUMA-G System.
New fund likely raising soon
The firm's newest fund is 4 to 7 years past its first sale and no newer Form D has been filed.
01 · Says / Does
| Tag | Says | Does |
|---|---|---|
| Stages | Not stated | Not enough dated deals |
| Sectors | Medical devices | Not enough dated deals |
| Regions | Not stated | Not enough dated deals |
Says: what the firm's funds state. Does: from 0 dated deals in the last 24 months.
02 · Fund history
| Fund | Year | Size | Status |
|---|---|---|---|
| Hunniwell Lake Ventures Medical Device Fund I, LLC | 2020 | $4M to $100M (Form D) | Follow-ons only |
03 · People across funds
- Sin Yew Teo
Hunniwell Lake Ventures Medical Device Fund I, LLC (Named on Form D)
- Daniel Teo, Managing Partner and Founder
- David Schechter, Operating Partner
- David Yeow, Principal
- John Ashley, Entrepreneur-in-Residence
- Matthew Otten, Operations Consultant
- Richard Fang, Managing Partner and Founder
04 · Recent deals
No dated deals found yet.
05 · Latest from the firm
No news from the firm's website yet.
06 · Sources
- http://www.hunniwell.com
- https://hunniwell.com/contact-us/
- https://hunniwell.com/news/
- https://hunniwell.com/team/
- https://hunniwell.com/about/
Fund dates and sizes are from SEC Form D filings.
Last verified: Oct 25, 2026